THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 96 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $577,000 | +42.5% | 22,290 | +7.2% | 0.03% | +40.0% |
Q3 2019 | $405,000 | +5.5% | 20,790 | +38.6% | 0.02% | -20.0% |
Q4 2018 | $384,000 | +14.3% | 15,005 | +45.6% | 0.02% | +66.7% |
Q3 2018 | $336,000 | +9.4% | 10,306 | -24.0% | 0.02% | +25.0% |
Q2 2018 | $307,000 | -55.8% | 13,561 | -74.6% | 0.01% | -47.8% |
Q2 2015 | $694,000 | -22.3% | 53,379 | -10.9% | 0.02% | -30.3% |
Q4 2014 | $893,000 | – | 59,885 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |